Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer
Year: 2019
Type: article
Source: Gastric Cancer
Institutions: Juntendo University, National Cancer Center Hospital East
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2909349708
